Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T04:28:43.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section with Arizona and Minnesota as study sites. Removed HHS Vulnerability Disclosure and the previous Arizona/Minnesota Location entries; page revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-24T13:49:42.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Editorial updates in Publications clarify that entries are automatically filled from PubMed and the page revision is now v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page removed the general funding-status notice related to government funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:18:58.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Minor formatting adjustments and wording changes were made to the Study Details page, including layout tweaks to the Study Overview and Study Dates sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:18:14.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a link to operating details, plus a new version tag (v3.2.0). - Removed references to older revision (v3.1.0) and two disease terms (Mucosa-associated lymphoma; B-cell chronic lymphocytic leukemia).
    Difference
    2%
    Check dated 2025-10-06T05:39:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.